VICP Registry Case Source Bundle Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_21-vv-02103 Package ID: USCOURTS-cofc-1_21-vv-02103 Petitioner: K.A. Filed: 2021-10-29 Decided: 2026-02-25 Vaccine: influenza Vaccination date: 2018-11-08 Condition: immune thrombocytopenic purpura (ITP) Outcome: compensated Award amount USD: 80000 AI-assisted case summary: On October 29, 2021, Natosha Dye filed a petition on behalf of K.A., a minor child, alleging that K.A. developed immune thrombocytopenic purpura after receiving an influenza vaccine on November 8, 2018. Respondent denied that the flu vaccine caused K.A.'s ITP and denied that any current condition was a sequela of a vaccine-related injury. The public stipulation does not state K.A.'s exact age, platelet counts, bleeding symptoms, hospitalization, medication history, or recovery course. On February 25, 2026, Special Master Herbrina D. S. Young adopted the parties' stipulation and awarded $80,000.00. The award was payable through counsel's IOLTA account for prompt disbursement to Ms. Dye as guardian or conservator of K.A.'s estate. K.A. was represented by Edward Kraus of Kraus Law Group, LLC. Theory of causation field: Influenza vaccine on November 8, 2018 causing ITP in minor child K.A.; exact age not stated in public stipulation. COMPENSATED by stipulation. Respondent denied vaccine causation and vaccine-related sequelae; public text lacks platelet/treatment chronology. Award $80,000 to counsel IOLTA for guardian/conservator disbursement. SM Herbrina D. S. Young; petition October 29, 2021; decision February 25, 2026. Attorney Edward Kraus, Kraus Law Group. Public staged source text: ================================================================================ DOCUMENT 1: USCOURTS-cofc-1_21-vv-02103-0 Date issued/filed: 2026-03-24 Pages: 8 Docket text: PUBLIC DECISION (Originally filed: 2/25/2026) regarding 57 DECISION Stipulation/Proffer. Signed by Special Master Herbrina D S Young. (gf) Service on parties made. -------------------------------------------------------------------------------- Case 1:21-vv-02103-UNJ Document 60 Filed 03/24/26 Page 1 of 8 In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS Filed: February 25, 2026 * * * * * * * * * * * * * * * * NATOSHA DYE, parent of K.A., a minor, * * Petitioner, * No. 21-2103V * v. * Special Master Young * SECRETARY OF HEALTH * AND HUMAN SERVICES, * * Respondent. * * * * * * * * * * * * * * * * * Edward Kraus, Kraus Law Group, LLC, Chicago, IL, for Petitioner. Camille Michelle Collett, United States Department of Justice, Washington, DC, for Respondent. DECISION1 On October 29, 2021, Natosha Dye (“Petitioner”) filed a petition for compensation pursuant to the National Vaccine Injury Compensation Program2 on behalf of her minor child, K.A. 42 U.S.C. §§ 300aa-10 to -34 (2018); Pet., ECF No. 1. Petitioner alleged that K.A. suffered from immune thrombocytopenic purpura (“ITP”) as a result of an influenza (“flu”) vaccine K.A. received on November 8, 2018. Id. On February 25, 2026, the parties filed a stipulation (attached as Appendix A) in which they state that a decision should be entered awarding compensation to Petitioner. Stipulation ¶ 7, ECF No. 56. Respondent “denies that K.A.’s alleged ITP or its residual effects were caused-in- fact by the flu vaccine; and denies that the flu vaccine caused K.A. any other injury or K.A.’s current condition.” Id. ¶ 6. Nevertheless, the parties agree to the joint stipulation. See id. ¶ 7. I find the stipulation reasonable and adopt it as the decision of the Court in awarding damages, on the terms set forth therein. 1 Because this Decision contains a reasoned explanation for the action taken in this case, it must be made publicly accessible and will be posted on the United States Court of Federal Claims’ website, and/or at https://www.govinfo.gov/app/collection/uscourts/national/cofc, in accordance with the E-Government Act of 2002. 44 U.S.C. § 3501 note (2018) (Federal Management and Promotion of Electronic Government Services). This means the Decision will be available to anyone with access to the internet. In accordance with Vaccine Rule 18(b), Petitioner has 14 days to identify and move to redact medical or other information, the disclosure of which would constitute an unwarranted invasion of privacy. If, upon review, I agree that the identified material fits within this definition, I will redact such material from public access. 2 National Childhood Vaccine Injury Act of 1986, Pub L. No. 99-660, 100 Stat. 3755. 1 Case 1:21-vv-02103-UNJ Document 60 Filed 03/24/26 Page 2 of 8 The parties stipulate that Petitioner shall receive the following compensation: (a) A lump sum of $80,000.00, to be paid through an ACH deposit to Petitioner’s counsel’s IOLTA account for prompt disbursement to Petitioner as guardian/conservator of K.A.’s estate. Id. ¶ 8. This amount represents compensation for all damages that would be available under 42 U.S.C. § 300aa-15(a). I approve the requested amount for Petitioner’s compensation. Accordingly, an award should be made consistent with the stipulation. In the absence of a motion for review filed pursuant to RCFC Appendix B, the Clerk of Court SHALL ENTER JUDGMENT in accordance with the terms of the parties’ stipulation.3 IT IS SO ORDERED. s/Herbrina D. S. Young Herbrina D. S. Young Special Master 3 Pursuant to Vaccine Rule 11(a), entry of judgment is expedited by the parties’ joint filing of notice renouncing the right to seek review. 2 Case 1:21-vv-02103-UNJ Document 60 Filed 03/24/26 Page 3 of 8 Case 1:21-vv-02103-UNJ Document 60 Filed 03/24/26 Page 4 of 8 Case 1:21-vv-02103-UNJ Document 60 Filed 03/24/26 Page 5 of 8 Case 1:21-vv-02103-UNJ Document 60 Filed 03/24/26 Page 6 of 8 Case 1:21-vv-02103-UNJ Document 60 Filed 03/24/26 Page 7 of 8 Case 1:21-vv-02103-UNJ Document 60 Filed 03/24/26 Page 8 of 8